TMB-365

BIOLOGICAL2 trials

Sponsors

TaiMed Biologics Inc.

Conditions

HIV -1 InfectionHIV-1-infection

Phase 1

Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants

CompletedNCT04027387

TaiMed Biologics Inc.HIV-1-infection

Start: 2019-12-14End: 2021-08-18Updated: 2021-10-06

Phase 2

HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study

RecruitingNCT07215468

TaiMed Biologics Inc.HIV -1 Infection

Start: 2025-12-16End: 2027-08-01Target: 75Updated: 2026-02-19